Review article: the use of potentially hepatotoxic drugs in patients with liver disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2008.03822.xPMID 18671777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced liver injury.

  2010cited by this paper
• Liver Disease Caused by Anesthetics, Toxins, and Herbal Preparations

  2010cited by this paper
• Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease

  2009cited by this paper
• Relationship between daily dose of oral medications and idiosyncratic drug‐induced liver injury: Search for signals

  2008cited by this paper
• Comment on "Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose".

  2008cited by this paper
• Lifestyle or Life-Saving Medicines? A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins

  2008cited by this paper
• Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.

  2008cited by this paper
• The current state of serum biomarkers of hepatotoxicity.

  2008cited by this paper
• Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose.

  2008cited by this paper
• Assessment of drug‐induced liver injury in clinical practice

  2008cited by this paper
• Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review

  2008cited by this paper
• Concurrent use of methotrexate and acitretin revisited

  2008cited by this paper
• Chronic hepatitis B: preventing, detecting, and managing viral resistance.

  2008cited by this paper
• Pharmacogenomics of anti-TB drugs-related hepatotoxicity.

  2008cited by this paper
• Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial

  2008cited by this paper
• Viral hepatitis and HIV coinfection.

  2008cited by this paper
• Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatran.

  2008cited by this paper
• Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?

  2007cited by this paper
• A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease

  2007cited by this paper
• Cancer chemotherapy II: atypical hepatic injuries.

  2007cited by this paper
• Herbal medicine in the treatment of liver diseases.

  2007cited by this paper
• Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

  2007cited by this paper
• Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products.

  2007cited by this paper
• Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial

  2007cited by this paper
• Combination of N‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis

  2007cited by this paper
• Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.

  2007cited by this paper
• Drug-induced liver injury associated with HIV medications.

  2007cited by this paper
• Acute liver failure: Summary of a workshop

  2007cited by this paper
• Special Considerations and Treatment of Patients with HBV-HIV Coinfection

  2007cited by this paper
• Antibiotic therapy: a major cause of drug-induced jaundice in southwest England

  2007cited by this paper
• Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens

  2007cited by this paper
• Promoting older adults’ well-being through Internet training and use

  2007cited by this paper
• Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.

  2007cited by this paper
• Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.

  2007cited by this paper
• The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis

  2007cited by this paper
• Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection.

  2007cited by this paper
• A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol

  2007cited by this paper
• Terbinafine-Induced Acute Autoimmune Hepatitis in the Setting of Hepatitis B Virus Infection

  2007cited by this paper
• Hepatotoxicity due to antibiotics.

  2007cited by this paper
• Acetaminophen Usage Patterns and Concentrations of Glutathione and γ‐Glutamyl Transferase in Alcoholic Subjects

  2007cited by this paper
• The HBV drug entecavir - effects on HIV-1 replication and resistance.

  2007cited by this paper
• Case Series on the Safe Use of Buprenorphine/Naloxone in Individuals with Acute Hepatitis C Infection and Abnormal Hepatic Liver Transaminases

  2007cited by this paper
• Cancer chemotherapy I: hepatocellular injury.

  2007cited by this paper
• Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.

  2007cited by this paper
• Herbal hepatotoxicity.

  2007cited by this paper
• Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial

  2007cited by this paper
• Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well‐being in patients with chronic hepatitis C

  2006cited by this paper
• Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature.

  2006cited by this paper
• An assessment of statin safety by hepatologists.

  2006cited by this paper
• Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection.

  2006cited by this paper
• Drug-related hepatotoxicity.

  2006cited by this paper
• Drug-related hepatotoxicity.

  2006cited by this paper
• Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

  2006cited by this paper
• Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.

  2006cited by this paper
• A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

  2006cited by this paper
• Re‐evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large‐scale population study

  2006cited by this paper
• Drug Induced Liver Injury Network (DILIN) Prospective Study: Initial Results

  2006cited by this paper
• Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.

  2006cited by this paper
• Hepatic injury.

  2006cited by this paper
• American Thoracic Society Documents An Official ATS Statement : Hepatotoxicity of Antituberculosis Therapy

  2006cited by this paper
• Statins and hepatic steatosis: Perspectives from the Dallas Heart Study

  2006cited by this paper
• Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.

  2006cited by this paper
• Statins, cardiovascular disease, and drug safety.

  2006cited by this paper
• Colesevelam hydrochloride in the management of dyslipidemia

  2006cited by this paper
• Case Report: Aminotransferase Elevation in HIV/Hepatitis B Virus Co-infected Patients Treated with Two Active Hepatitis B Virus Drugs

  2006cited by this paper
• Incidence of statin hepatotoxicity in patients with hepatitis C.

  2006cited by this paper
• Severe hepatic side effects of ezetimibe.

  2006cited by this paper
• Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo

  2005cited by this paper
• Herbal hepatotoxicity.

  2005cited by this paper
• Experience with statin use in patients with chronic hepatitis C infection.

  2005cited by this paper
• Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization.

  2005cited by this paper
• Dose Adjustment in Patients with Liver Disease

  2005cited by this paper
• Patients with Elevated Baseline Liver Enzymes Do Not Have Higher Frequency of Hepatotoxicity from Lovastatin than Those with Normal Baseline Liver Enzymes

  2005cited by this paper
• Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

  2005cited by this paper
• Statins and hepatotoxicity: Focus on patients with fatty liver

  2005cited by this paper
• Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.

  2005cited by this paper
• Hepatobiliary tuberculosis

  2005cited by this paper
• Ezetimibe/Simvastatin (vytorin) for hypercholesterolemia.

  2005cited by this paper
• Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

  2005cited by this paper
• Propylthiouracil for alcoholic liver disease.

  2005cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• Hepatotoxicity of Antiretrovirals

  2005cited by this paper
• Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.

  2005cited by this paper
• Over-the-Counter Statins

  2005cited by this paper
• Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

  2005cited by this paper
• Successful Treatment of Hyperthyroidism with Amiodarone in a Patient with Propylthiouracil-Induced Acute Hepatic Failure

  2004cited by this paper
• Diagnosis, management, and treatment of hepatitis C

  2004cited by this paper
• Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors.

  2004cited by this paper
• Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.

  2004cited by this paper
• Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors.

  2004cited by this paper
• Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status

  2004cited by this paper
• Are patients with elevated liver tests at increased risk of drug-induced liver injury?

  2004cited by this paper
• Statins and Liver Toxicity: A Meta‐Analysis

  2004cited by this paper
• The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients.

  2004cited by this paper
• A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

  2004cited by this paper
• Use of herbal supplements for chronic liver disease.

  2004cited by this paper
• Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

  2004cited by this paper
• Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance

  2004cited by this paper
• Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study.

  2004cited by this paper
• Is there value in liver function test and creatine phosphokinase monitoring with statin use?

  2004cited by this paper

• Investigation of in vitro protective effects of Mucor racemosus-fermented pine pollen on alcoholic fatty liver and its bioactive components

  2025cites this paper
• Alanine aminotransferase cutoffs for the pediatric fatty liver disease: Major impact of the reference population.

  2023cites this paper
• Association between potential supplement-drug interactions and liver diseases in patients with cancer: A large prospective cohort study.

  2023cites this paper
• Heat-Killed Enterococcus faecalis EF-2001 Attenuate Lipid Accumulation in Diet-Induced Obese (DIO) Mice by Activating AMPK Signaling in Liver

  2022cites this paper
• Acute Multi-Organ Toxicity During 24-Hour Dosing of Intravenous Amiodarone: A Case Report

  2022cites this paper
• Metabolic support of antiviral therapy in patients with COVID-19

  2022cites this paper
• Systematic Review of Antifungal-Induced Acute Liver Failure

  2021cites this paper
• A retrospective case-controlled cohort study of inpatient drug induced liver injury: the RIDDLE study.

  2020cites this paper
• Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors

  2020cites this paper
• Fungal Infections in Immunocompromised Hosts

  2019cites this paper
• Centre-based Evaluation of Some Biochemical Effects of the Initial Phase of Anti-tuberculosis Therapy in Bayelsa State

  2019cites this paper
• Prescribing in chronic severe hepatic impairment.

  2019cites this paper
• Antiviral therapy for hepatitis B prevents liver injury in patients with tuberculosis and hepatitis B co-infection.

  2019cites this paper
• Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations

  2019cites this paper
• The evolution of ideas about medicinal liver damage

  2019influential citation
• Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms

  2019cites this paper
• Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice

  2019cites this paper
• [The efficacy of remaxol as a hepatoprotective agent in long-term psychopharmacotherapy].

  2019cites this paper
• [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features].

  2019cites this paper
• Answers to multiple choice questions

  2019cites this paper
• Attempts to Limit Opioid Prescribing in Critically Ill Patients: Not So Easy, Not So Fast

  2019cites this paper
• Pre-Existing Liver Disease and Toxicity of Antifungals

  2018cites this paper
• Latent tuberculosis in patients with hepatitis C infection before receiving antiretroviral drugs

  2018cites this paper
• The Parallel Testing of Isolated Rat Liver and Kidney Mitochondria Reveals a Calcium‐Dependent Sensitivity to Diclofenac and Ibuprofen

  2018cites this paper
• Drugs and Toxins

  2018cites this paper
• Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long‐term Treatment With Tumor Necrosis Factor Antagonists

  2018cites this paper
• A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets

  2017cites this paper
• Drug metabolism and liver disease: a drug–gene–environment interaction

  2017influential citation
• Mechanistic Approach for Toxic Effects of Bupropion in Primary Rat Hepatocytes

  2017cites this paper
• Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.

  2017cites this paper
• Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?

  2017cites this paper
• Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.

  2016cites this paper
• Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review

  2016cites this paper
• The pharmacotherapy of cirrhosis: concerns and proposed investigations and solutions

  2016cites this paper
• Evaluation of serum iron and ferritin in different treatment regimens for chronic hepatitis C virus

  2016cites this paper
• CAM/Drug-Induced Hepatotoxicity: Implications in Viral Hepatitis

  2016cites this paper
• [DRUG-INDUCED LIVER DISEASE IN MULTICOMPONENT THERAPY OF COMORBID CONDITIONS].

  2015cites this paper
• Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro.

  2015cites this paper
• The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.

  2015cites this paper
• Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options

  2015cites this paper
• Prise en charge de la douleur chez le cirrhotique : un dilemme ?

  2015cites this paper
• Farmacovigilância em tuberculose: relato de uma experiência no Brasil Pharmacovigilance in tuberculosis: report of an experience in Brazil

  2015cites this paper
• Causality assessment: Which is best—expert opinion or RUCAM?

  2014cites this paper
• Medication prescribing in liver dysfunction

  2014cites this paper
• ¿Son las estatinas hepatotóxicas o hepatoprotectoras? Revisión bibliográfica y actualización científica

  2014cites this paper
• Complementary and alternative medications in hepatitis C infection.

  2014cites this paper
• Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.

  2014cites this paper
• Traineesâ Attitudes and Preferences towards the Use of Over the CounterAnalgesics in Patients with Chronic Liver Disease

  2014cites this paper
• Application of urine proteomics for biomarker discovery in drug-induced liver injury

  2014cites this paper
• Drug-induced liver injury: what was new in 2013?

  2014cites this paper
• Use of contraindicated drugs in patients with chronic liver disease: a therapeutic dilemma.

  2013cites this paper
• Hepatotoxicity and drug interactions in liver transplant candidates and recipients.

  2013influential citation
• Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic

  2013cites this paper
• Hepatotoxicity of antibiotics: a review and update for the clinician.

  2013cites this paper
• Review article: prescribing medications in patients with cirrhosis – a practical guide

  2013influential citation
• Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist

  2013cites this paper
• Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database

  2013cites this paper
• Drug‐Induced Liver Injury: The Role of Drug Metabolism and Transport

  2013cites this paper
• THE CEYLON MEDICAL JOURNAL

  2013cites this paper
• Answers to multiple choice questions.

  2012cites this paper
• A guide to the management of tuberculosis in patients with chronic liver disease.

  2012cites this paper
• Answers to multiple choice questions.

  2012cites this paper
• 13 – Hepatic injury due to drugs, herbal compounds, chemicals and toxins

  2012cites this paper
• Current Challenges and Controversies in Drug-Induced Liver Injury

  2012cites this paper
• Drug-induced liver disease.

  2012cites this paper
• Drug-induced liver injury: a summary of recent advances

  2011cites this paper
• Acute-on-chronic liver failure: concept, natural history, and prognosis

  2011cites this paper
• The Liver in Systemic Disease

  2011cites this paper
• Drug‐Induced Liver Injury

  2011cites this paper
• The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports

  2010cites this paper
• SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

  2010cites this paper
• Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.

  2010cites this paper
• Predicting and preventing acute drug-induced liver injury: what's new in 2010?

  2010cites this paper
• A fourth dimension in decision making in hepatology

  2010cites this paper
• Hepatotoxicity Fears Contribute to Underutilization of Statin Medications by Primary Care Physicians

  2010cites this paper
• Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais - parte 1: fármacos de primeira linha

  2010cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease

  2010cites this paper
• Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.

  2010cites this paper
• Liver injury caused by drugs: an update.

  2010cites this paper
• Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs.

  2010cites this paper
• Drug-induced liver injury.

  2010cites this paper
• Drug-induced Liver Injury.

  2010cites this paper
• Epidemiology of idiosyncratic drug-induced liver injury.

  2009cites this paper
• Drug-induced liver injury: what was new in 2008?

  2009influential citation
• Acute Hepatic Injury Associated with Varenicline in a Patient with Underlying Liver Disease

  2009cites this paper
• Epidemiology of Idiosyncratic Drug-Induced Liver Injury

  2009cites this paper
• A Review of Scientific Papers About Head and Neck Cancers

  2008cites this paper
• Radiotherapy, cancer and some anatomical structures related with the pelvic floor: an evaluation of the scientific literature

  2008cites this paper